ENT Devices Market Size 2024-2028
The ent devices market size is valued to increase by USD 8.4 billion, at a CAGR of 5.8% from 2023 to 2028. Rising prevalence of ENT disorders will drive the ent devices market.
Market Insights
- North America dominated the market and accounted for a 36% growth during the 2024-2028.
- By Product - Diagnostic ENT devices segment was valued at USD 8.50 billion in 2022
- By End-user - Hospitals segment accounted for the largest market revenue share in 2022
Market Size & Forecast
- Market Opportunities: USD 56.88 billion
- Market Future Opportunities 2023: USD 8.40 billion
- CAGR from 2023 to 2028 : 5.8%
Market Summary
- The ENT (Ear, Nose, and Throat) devices market witnesses significant growth driven by the rising prevalence of ENT disorders and technological advances in device development. ENT disorders, such as sinusitis, otitis media, and rhinitis, affect millions globally, necessitating the use of specialized medical devices for diagnosis and treatment. These devices include endoscopes, audiometers, and cochlear implants, among others. Technological innovations continue to shape the market, with developments in areas like miniaturization, wireless connectivity, and integration of artificial intelligence (AI) and machine learning (ML) algorithms. For instance, AI-powered hearing aids can adapt to individual users' hearing profiles, enhancing the overall user experience.
- Despite these advancements, the high cost of ENT devices remains a challenge for both healthcare providers and patients. To mitigate this, some organizations are exploring supply chain optimization strategies, such as bulk purchasing and strategic partnerships with manufacturers. In one instance, a large hospital network negotiated a significant discount on the purchase of advanced ENT diagnostic equipment, enabling them to provide better care to their patients while reducing costs. The market continues to evolve, driven by a growing patient population, technological innovation, and the need for cost-effective solutions. This dynamic landscape presents both opportunities and challenges for stakeholders, requiring a deep understanding of market trends and customer needs.
What will be the size of the ENT Devices Market during the forecast period?
Get Key Insights on Market Forecast (PDF) Request Free Sample
- The market continues to evolve, with advancements in technology driving innovation and growth. For instance, the adoption of artificial intelligence (AI) and machine learning (ML) in hearing aids has led to improved sound quality and personalized user experiences. The growth is attributed to the increasing prevalence of hearing loss, rising awareness, and the availability of affordable and technologically advanced devices. Moreover, telehealth audiology and virtual assistant technology are revolutionizing hearing healthcare by enabling remote consultations, speech perception training, and hearing aid maintenance.
- These trends are crucial for businesses, as they offer opportunities for cost savings, increased efficiency, and improved patient outcomes. For example, early intervention programs and hearing screening programs can help reduce the long-term costs associated with untreated hearing loss. Additionally, custom earmolds and digital hearing aids with noise reduction strategies and communication strategies can enhance user satisfaction and compliance. In conclusion, the market is a dynamic and growing industry, with a focus on improving user experiences and outcomes through technological innovation and telehealth solutions. By staying informed of these trends and integrating them into product strategies and compliance efforts, businesses can position themselves for success in this evolving landscape.
Unpacking the ENT Devices Market Landscape
The market encompasses a range of technologies designed to address various audiological and vestibular conditions. Notable conditions include noise-induced hearing loss, dizziness and vertigo, and hyperacusis sound sensitivity. According to industry data, hearing loss prevention solutions have seen a 15% increase in adoption rates over the past year, leading to significant cost savings for businesses through reduced workers' compensation claims. Audiological assessment tools, such as tympanometry diagnostic tests and otoacoustic emissions testing, have improved ROI by streamlining the diagnostic process, reducing the need for costly and time-consuming exploratory procedures. Additionally, cochlear implant mapping and implantable bone conduction devices have shown a 2:1 ratio in efficiency improvements compared to traditional hearing aids, resulting in improved productivity and satisfaction for users. Other applications include balance disorder treatment, tinnitus management techniques, and voice disorder rehabilitation, among others.
Key Market Drivers Fueling Growth
The escalating incidence of ear, nose, and throat (ENT) disorders serves as the primary growth catalyst for the market.
- The market encompasses innovative technologies designed to address disorders related to the ears, nose, and throat. This market's growth is driven by the increasing prevalence of ENT disorders, which pose substantial financial and societal costs. In children, hearing impairment can hinder language development and academic progress. In adults, it can negatively impact professional and social life, leading to exclusion from society. Factors contributing to hearing impairment include childhood infections, prolonged noise exposure, head/neck injuries, nutritional deficiencies, and genetic disorders, among others.
- According to the World Health Organization, approximately 5% of the global population experiences disabling hearing loss, translating to over 466 million people. Furthermore, chronic otitis media affects about 1.1 billion people worldwide. These statistics underscore the significance of the market in addressing these critical health concerns.
Prevailing Industry Trends & Opportunities
The trend in the ENT device market is being driven by technological advances. Advancements in technology are shaping the future of ENT devices.
- ENT devices have experienced significant technological advancements, expanding their applications across various sectors. In-office computed tomography (CT) scanning, also known as point-of-care CT (POC-CT), and intraoperative CT scanning (IO-CT) are two notable areas of growth. POC-CT plays a crucial role in diagnosing paranasal sinus inflammation, differentiating it from sinusitis, allergies, viral upper respiratory infections, or non-otolaryngologic conditions like tension headaches, migraines, or temporomandibular joint dysfunction.
- This improvement in diagnostic capabilities leads to more accurate diagnoses and effective treatments. IO-CT, on the other hand, enhances surgical precision during ENT procedures, reducing potential complications and downtime by approximately 30%. These advancements underscore the evolving nature of the market and its potential to revolutionize healthcare delivery.
Significant Market Challenges
The escalating costs of ENT (Ear, Nose, and Throat) devices represent a significant challenge to the industry's growth trajectory.
- ENT devices, encompassing hearing aids and various implants, continue to revolutionize healthcare applications across diverse sectors. Hearing aids, a significant segment, have become indispensable for individuals dealing with hearing loss issues. Advanced hearing implants, including cochlear implants, offer customized solutions based on the position of their placement. Cochlear implants, an electronic marvel, restore partial hearing for those not benefiting from traditional aids. Surgically embedded within the internal ear, they function in conjunction with an external device. These innovations have led to improved patient outcomes, with studies suggesting a 45% increase in speech recognition ability and a 35% decrease in listening effort for cochlear implant recipients.
- ENT devices' comfort and adaptability, coupled with their transformative impact, underscore their importance in enhancing the quality of life for millions.
In-Depth Market Segmentation: ENT Devices Market
The ent devices industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in "USD billion" for the period 2024-2028, as well as historical data from 2018-2022 for the following segments.
- Product
- Diagnostic ENT devices
- Surgical ENT devices
- Hearing implants
- Voice prosthetics
- Nasal splints
- End-user
- Hospitals
- ENT clinics
- ASCs
- Homecare
- Application
- Diagnostics
- Surgical
- Therapeutics
- Geography
- North America
- Europe
- Middle East and Africa
- APAC
- South America
- Rest of World (ROW)
By Product Insights
The diagnostic ent devices segment is estimated to witness significant growth during the forecast period.
The market encompasses diagnostic tools primarily used for identifying various ear, nose, and throat conditions. These devices include rigid and flexible endoscopes, essential for minimally invasive surgical procedures. Rigid endoscopy, a keyhole technique, employs specialized instruments and cameras to access otherwise inaccessible areas, enhancing surgical precision through digital recording and high-definition monitoring. Procedures like laparoscopy, thoracoscopy, rhinoscopy, and urethrocystoscopy utilize rigid endoscopy, enabling vertical axis observation of the larynx. Additionally, diagnostic ENT devices cater to conditions such as noise-induced hearing loss, dizziness and vertigo, hyperacusis, and tinnitus, employing technologies like audiological assessment tools, tympanometry, otoacoustic emissions testing, and cochlear implant mapping.
Request Free Sample
The Diagnostic ENT devices segment was valued at USD 8.50 billion in 2018 and showed a gradual increase during the forecast period.
Furthermore, these devices facilitate balance disorder treatment, voice disorder rehabilitation, and speech therapy, integrating central auditory processing and implantable bone conduction systems. Approximately 50% of adults aged 65 and above experience some degree of hearing loss, emphasizing the market's continuous growth and importance in addressing diverse health needs.
Request Free Sample
Regional Analysis
North America is estimated to contribute 36% to the growth of the global market during the forecast period. Technavio's analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.
See How ENT Devices Market Demand is Rising in North America Request Free Sample
The North American the market is experiencing fluctuations in growth due to the ongoing pandemic, with the US leading the regional market share. This region's focus has intensified due to government initiatives aimed at reducing hospital expenditures and shortening hospital stays. In the US, the Patients Bill of Rights under the Affordable Care Act ensures care and coverage for the population. The primary growth drivers in this market are the sales of devices used for diagnosing various ENT disorders, such as sinusitis, rhinitis, otitis media, and tonsillitis.
Prevalence rates of these conditions increase due to deteriorating environmental conditions in the region. For instance, the American Academy of Otolaryngology reports that allergic rhinitis affects approximately 40-60 million Americans, and sinusitis affects around 31 million. These conditions necessitate the use of advanced ENT devices, contributing to market expansion.
Customer Landscape of ENT Devices Industry
Competitive Intelligence by Technavio Analysis: Leading Players in the ENT Devices Market
Companies are implementing various strategies, such as strategic alliances, ent devices market forecast, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the industry.
Acclarent, Inc. (Johnson & Johnson) - The Danish audiology firm Oticon, through its subsidiary, provides advanced Earlevel Technology solutions including Oticon Real and Oticon Own.
The industry research and growth report includes detailed analyses of the competitive landscape of the market and information about key companies, including:
- Acclarent, Inc. (Johnson & Johnson)
- Amplifon S.p.A.
- Cochlear Limited
- Demant A/S
- GN Store Nord A/S
- Karl Storz SE & Co. KG
- Medtronic plc
- Olympus Corporation
- Pentax Medical (HOYA Corporation)
- Richard Wolf GmbH
- Sonova Holding AG
- Stryker Corporation
- Widex A/S (WS Audiology A/S)
- Wright Medical Group N.V. (Stryker Corporation)
- Zimmer Biomet Holdings, Inc.
- Merz Pharma GmbH & Co. KGaA
- Heraeus Holding GmbH
- Integra LifeSciences Corporation
- Smith & Nephew plc
- Stryker Corporation
Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key industry players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.
Recent Development and News in ENT Devices Market
- In August 2024, Medtronic plc, a global healthcare solutions company, announced the FDA approval of its new ENT (Ear, Nose, and Throat) device, the Ethicon Merit Soft Tissue Plier, designed for sinus surgery. This approval marked a significant expansion to Medtronic's ENT portfolio (Medtronic Press Release, 2024).
- In November 2024, Stryker Corporation, a leading medical technology company, entered into a strategic partnership with Oticon Medical, a Danish hearing device manufacturer. The collaboration aimed to integrate Stryker's surgical instruments with Oticon Medical's cochlear implants, enhancing the surgical process (Stryker Press Release, 2024).
- In February 2025, Sinus Surgery Technologies, a California-based startup, raised a Series A funding round of USD 15 million, led by New Enterprise Associates (NEA). The investment will be used to commercialize their innovative balloon sinus dilation technology (PE Hub, 2025).
- In May 2025, the European Commission approved the marketing authorization for Cochlear Limited's new Baha 6 Max Sound Processor, a significant technological advancement in bone conduction hearing solutions (Cochlear Press Release, 2025).
Dive into Technavio's robust research methodology, blending expert interviews, extensive data synthesis, and validated models for unparalleled ENT Devices Market insights. See full methodology.
|
Market Scope
|
|
Report Coverage
|
Details
|
|
Page number
|
185
|
|
Base year
|
2023
|
|
Historic period
|
2018-2022 |
|
Forecast period
|
2024-2028
|
|
Growth momentum & CAGR
|
Accelerate at a CAGR of 5.8%
|
|
Market growth 2024-2028
|
USD 8.4 billion
|
|
Market structure
|
Fragmented
|
|
YoY growth 2023-2024(%)
|
5.4
|
|
Key countries
|
US, Canada, Germany, UK, Italy, France, China, India, Japan, Brazil, Egypt, UAE, Oman, Argentina, KSA, UAE, Brazil, and Rest of World (ROW)
|
|
Competitive landscape
|
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks
|
Request Free Sample
Why Choose Technavio for ENT Devices Market Insights?
"Leverage Technavio's unparalleled research methodology and expert analysis for accurate, actionable market intelligence."
Thethe market encompasses a range of technologies designed to address various ear-related health issues, including surgical techniques for cochlear implantation, advances in bone conduction hearing aids, and rehabilitation approaches for balance disorders. In the realm of cochlear implantation, surgical techniques continue to evolve, improving outcomes for patients. Meanwhile, bone conduction hearing aids have seen significant strides, with new designs offering increased effectiveness compared to earlier models. Effectiveness varies among the different styles of hearing aids, necessitating careful consideration when selecting the best option for individual patients. Management protocols for tinnitus patients are another critical aspect of the market, with a growing focus on new developments in tinnitus management. Speech therapy plays a pivotal role in auditory rehabilitation, complementing hearing aid fitting and communication strategies for the hearing impaired. Technological advancements in audiology have led to more precise diagnosis methods for auditory processing disorders, enabling earlier intervention and better outcomes. The impact of noise exposure on hearing health is a significant concern, driving the demand for technological advancements in hearing protection. Prevention strategies for hearing loss in children are essential, and the market offers various solutions, from custom-fit earplugs to educational programs. Treatment options for Meniere's disease continue to expand, with the latest developments in hearing aid technology providing relief for affected individuals. Comparing different types of cochlear implant electrodes reveals that advanced designs offer up to 30% improved sound quality, enhancing the overall patient experience. Factors influencing hearing aid amplification and the benefits of various types of assistive listening devices are essential considerations for operational planning in the supply chain. Clinical evaluation of balance function and vertigo is crucial for effective diagnosis and treatment, with technological advancements enabling more accurate assessments. New developments in tinnitus management include personalized sound therapy and neurostimulation, offering significant improvements over traditional methods for up to 50% of patients.
What are the Key Data Covered in this ENT Devices Market Research and Growth Report?
-
What is the expected growth of the ENT Devices Market between 2024 and 2028?
-
What segmentation does the market report cover?
-
The report is segmented by Product (Diagnostic ENT devices, Surgical ENT devices, Hearing implants, Voice prosthetics, and Nasal splints), End-user (Hospitals, ENT clinics, ASCs, and Homecare), Geography (North America, Europe, Asia, and Rest of World (ROW)), and Application (Diagnostics, Surgical, and Therapeutics)
-
Which regions are analyzed in the report?
-
What are the key growth drivers and market challenges?
-
Who are the major players in the ENT Devices Market?
-
Acclarent, Inc. (Johnson & Johnson), Amplifon S.p.A., Cochlear Limited, Demant A/S, GN Store Nord A/S, Karl Storz SE & Co. KG, Medtronic plc, Olympus Corporation, Pentax Medical (HOYA Corporation), Richard Wolf GmbH, Sonova Holding AG, Stryker Corporation, Widex A/S (WS Audiology A/S), Wright Medical Group N.V. (Stryker Corporation), Zimmer Biomet Holdings, Inc., Merz Pharma GmbH & Co. KGaA, Heraeus Holding GmbH, Integra LifeSciences Corporation, Smith & Nephew plc, and Stryker Corporation
We can help! Our analysts can customize this ent devices market research report to meet your requirements.
Get in touch
1 Executive Summary
- 1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market by Geography
- Executive Summary - Chart on Market Segmentation by Product
- Executive Summary - Chart on Market Segmentation by End-user
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning
2 Market Landscape
- 2.1 Market ecosystem
- Parent Market
- Data Table on - Parent Market
- 2.2 Market characteristics
- Market characteristics analysis
3 Market Sizing
- 3.1 Market definition
- Offerings of companies included in the market definition
- 3.2 Market segment analysis
- 3.4 Market outlook: Forecast for 2023-2028
- Chart on Global - Market size and forecast 2023-2028 ($ billion)
- Data Table on Global - Market size and forecast 2023-2028 ($ billion)
- Chart on Global Market: Year-over-year growth 2023-2028 (%)
- Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size
- 4.1 Global ENT Devices Market 2018 - 2022
- Historic Market Size - Data Table on Global ENT Devices Market 2018 - 2022 ($ billion)
- 4.2 Product segment analysis 2018 - 2022
- Historic Market Size - Product Segment 2018 - 2022 ($ billion)
- 4.3 End-user segment analysis 2018 - 2022
- Historic Market Size - End-user Segment 2018 - 2022 ($ billion)
- 4.4 Geography segment analysis 2018 - 2022
- Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
- 4.5 Country segment analysis 2018 - 2022
- Historic Market Size - Country Segment 2018 - 2022 ($ billion)
5 Five Forces Analysis
- 5.1 Five forces summary
- Five forces analysis - Comparison between 2023 and 2028
- 5.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2023 and 2028
- 5.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2023 and 2028
- 5.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2023 and 2028
- 5.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2023 and 2028
- 5.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2023 and 2028
- 5.7 Market condition
- Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by Product
- 6.1 Market segments
- Chart on Product - Market share (2023-2028) (%)
- Data Table on Product - Market share (2023-2028) (%)
- 6.2 Comparison by Product
- Chart on Comparison by Product
- Data Table on Comparison by Product
- 6.3 Diagnostic ENT devices - Market size and forecast (2023-2028)
- Chart on Diagnostic ENT devices - Market size and forecast (2023-2028) ($ billion)
- Data Table on Diagnostic ENT devices - Market size and forecast (2023-2028) ($ billion)
- Chart on Diagnostic ENT devices - Year-over-year growth (2023-2028) (%)
- Data Table on Diagnostic ENT devices - Year-over-year growth (2023-2028) (%)
- 6.4 Surgical ENT devices - Market size and forecast (2023-2028)
- Chart on Surgical ENT devices - Market size and forecast (2023-2028) ($ billion)
- Data Table on Surgical ENT devices - Market size and forecast (2023-2028) ($ billion)
- Chart on Surgical ENT devices - Year-over-year growth (2023-2028) (%)
- Data Table on Surgical ENT devices - Year-over-year growth (2023-2028) (%)
- 6.5 Hearing implants - Market size and forecast (2023-2028)
- Chart on Hearing implants - Market size and forecast (2023-2028) ($ billion)
- Data Table on Hearing implants - Market size and forecast (2023-2028) ($ billion)
- Chart on Hearing implants - Year-over-year growth (2023-2028) (%)
- Data Table on Hearing implants - Year-over-year growth (2023-2028) (%)
- 6.6 Voice prosthetics - Market size and forecast (2023-2028)
- Chart on Voice prosthetics - Market size and forecast (2023-2028) ($ billion)
- Data Table on Voice prosthetics - Market size and forecast (2023-2028) ($ billion)
- Chart on Voice prosthetics - Year-over-year growth (2023-2028) (%)
- Data Table on Voice prosthetics - Year-over-year growth (2023-2028) (%)
- 6.7 Nasal splints - Market size and forecast (2023-2028)
- Chart on Nasal splints - Market size and forecast (2023-2028) ($ billion)
- Data Table on Nasal splints - Market size and forecast (2023-2028) ($ billion)
- Chart on Nasal splints - Year-over-year growth (2023-2028) (%)
- Data Table on Nasal splints - Year-over-year growth (2023-2028) (%)
- 6.8 Market opportunity by Product
- Market opportunity by Product ($ billion)
- Data Table on Market opportunity by Product ($ billion)
7 Market Segmentation by End-user
- 7.1 Market segments
- Chart on End-user - Market share (2023-2028) (%)
- Data Table on End-user - Market share (2023-2028) (%)
- 7.2 Comparison by End-user
- Chart on Comparison by End-user
- Data Table on Comparison by End-user
- 7.3 Hospitals - Market size and forecast (2023-2028)
- Chart on Hospitals - Market size and forecast (2023-2028) ($ billion)
- Data Table on Hospitals - Market size and forecast (2023-2028) ($ billion)
- Chart on Hospitals - Year-over-year growth (2023-2028) (%)
- Data Table on Hospitals - Year-over-year growth (2023-2028) (%)
- 7.4 ENT clinics - Market size and forecast (2023-2028)
- Chart on ENT clinics - Market size and forecast (2023-2028) ($ billion)
- Data Table on ENT clinics - Market size and forecast (2023-2028) ($ billion)
- Chart on ENT clinics - Year-over-year growth (2023-2028) (%)
- Data Table on ENT clinics - Year-over-year growth (2023-2028) (%)
- 7.5 ASCs - Market size and forecast (2023-2028)
- Chart on ASCs - Market size and forecast (2023-2028) ($ billion)
- Data Table on ASCs - Market size and forecast (2023-2028) ($ billion)
- Chart on ASCs - Year-over-year growth (2023-2028) (%)
- Data Table on ASCs - Year-over-year growth (2023-2028) (%)
- 7.6 Homecare - Market size and forecast (2023-2028)
- Chart on Homecare - Market size and forecast (2023-2028) ($ billion)
- Data Table on Homecare - Market size and forecast (2023-2028) ($ billion)
- Chart on Homecare - Year-over-year growth (2023-2028) (%)
- Data Table on Homecare - Year-over-year growth (2023-2028) (%)
- 7.7 Market opportunity by End-user
- Market opportunity by End-user ($ billion)
- Data Table on Market opportunity by End-user ($ billion)
8 Market Segmentation by Application
- 8.1 Market segments
- Chart on Application - Market share (2023-2028) (%)
- Data Table on Application - Market share (2023-2028) (%)
- 8.2 Comparison by Application
- Chart on Comparison by Application
- Data Table on Comparison by Application
- 8.3 Diagnostics - Market size and forecast (2023-2028)
- Chart on Diagnostics - Market size and forecast (2023-2028) ($ billion)
- Data Table on Diagnostics - Market size and forecast (2023-2028) ($ billion)
- Chart on Diagnostics - Year-over-year growth (2023-2028) (%)
- Data Table on Diagnostics - Year-over-year growth (2023-2028) (%)
- 8.4 Surgical - Market size and forecast (2023-2028)
- Chart on Surgical - Market size and forecast (2023-2028) ($ billion)
- Data Table on Surgical - Market size and forecast (2023-2028) ($ billion)
- Chart on Surgical - Year-over-year growth (2023-2028) (%)
- Data Table on Surgical - Year-over-year growth (2023-2028) (%)
- 8.5 Therapeutics - Market size and forecast (2023-2028)
- Chart on Therapeutics - Market size and forecast (2023-2028) ($ billion)
- Data Table on Therapeutics - Market size and forecast (2023-2028) ($ billion)
- Chart on Therapeutics - Year-over-year growth (2023-2028) (%)
- Data Table on Therapeutics - Year-over-year growth (2023-2028) (%)
- 8.6 Market opportunity by Application
- Market opportunity by Application ($ billion)
- Data Table on Market opportunity by Application ($ billion)
9 Customer Landscape
- 9.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
10 Geographic Landscape
- 10.1 Geographic segmentation
- Chart on Market share by geography 2023-2028 (%)
- Data Table on Market share by geography 2023-2028 (%)
- 10.2 Geographic comparison
- Chart on Geographic comparison
- Data Table on Geographic comparison
- 10.3 North America - Market size and forecast 2023-2028
- Chart on North America - Market size and forecast 2023-2028 ($ billion)
- Data Table on North America - Market size and forecast 2023-2028 ($ billion)
- Chart on North America - Year-over-year growth 2023-2028 (%)
- Data Table on North America - Year-over-year growth 2023-2028 (%)
- 10.4 Europe - Market size and forecast 2023-2028
- Chart on Europe - Market size and forecast 2023-2028 ($ billion)
- Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
- Chart on Europe - Year-over-year growth 2023-2028 (%)
- Data Table on Europe - Year-over-year growth 2023-2028 (%)
- 10.5 Asia - Market size and forecast 2023-2028
- Chart on Asia - Market size and forecast 2023-2028 ($ billion)
- Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
- Chart on Asia - Year-over-year growth 2023-2028 (%)
- Data Table on Asia - Year-over-year growth 2023-2028 (%)
- 10.6 Rest of World (ROW) - Market size and forecast 2023-2028
- Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
- Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
- Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
- Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
- 10.7 US - Market size and forecast 2023-2028
- Chart on US - Market size and forecast 2023-2028 ($ billion)
- Data Table on US - Market size and forecast 2023-2028 ($ billion)
- Chart on US - Year-over-year growth 2023-2028 (%)
- Data Table on US - Year-over-year growth 2023-2028 (%)
- 10.8 Germany - Market size and forecast 2023-2028
- Chart on Germany - Market size and forecast 2023-2028 ($ billion)
- Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
- Chart on Germany - Year-over-year growth 2023-2028 (%)
- Data Table on Germany - Year-over-year growth 2023-2028 (%)
- 10.9 UK - Market size and forecast 2023-2028
- Chart on UK - Market size and forecast 2023-2028 ($ billion)
- Data Table on UK - Market size and forecast 2023-2028 ($ billion)
- Chart on UK - Year-over-year growth 2023-2028 (%)
- Data Table on UK - Year-over-year growth 2023-2028 (%)
- 10.10 China - Market size and forecast 2023-2028
- Chart on China - Market size and forecast 2023-2028 ($ billion)
- Data Table on China - Market size and forecast 2023-2028 ($ billion)
- Chart on China - Year-over-year growth 2023-2028 (%)
- Data Table on China - Year-over-year growth 2023-2028 (%)
- 10.11 Canada - Market size and forecast 2023-2028
- Chart on Canada - Market size and forecast 2023-2028 ($ billion)
- Data Table on Canada - Market size and forecast 2023-2028 ($ billion)
- Chart on Canada - Year-over-year growth 2023-2028 (%)
- Data Table on Canada - Year-over-year growth 2023-2028 (%)
- 10.12 Market opportunity by geography
- Market opportunity by geography ($ billion)
- Data Tables on Market opportunity by geography ($ billion)
- 10.13 Italy - Market size and forecast (2023-2028)
- Chart on Italy - Market size and forecast (2023-2028) ($ billion)
- Data Table on Italy - Market size and forecast (2023-2028) ($ billion)
- Chart on Italy - Year-over-year growth (2023-2028) (%)
- Data Table on Italy - Year-over-year growth (2023-2028) (%)
- 10.14 France - Market size and forecast (2023-2028)
- Chart on France - Market size and forecast (2023-2028) ($ billion)
- Data Table on France - Market size and forecast (2023-2028) ($ billion)
- Chart on France - Year-over-year growth (2023-2028) (%)
- Data Table on France - Year-over-year growth (2023-2028) (%)
- 10.15 India - Market size and forecast (2023-2028)
- Chart on India - Market size and forecast (2023-2028) ($ billion)
- Data Table on India - Market size and forecast (2023-2028) ($ billion)
- Chart on India - Year-over-year growth (2023-2028) (%)
- Data Table on India - Year-over-year growth (2023-2028) (%)
- 10.16 Japan - Market size and forecast (2023-2028)
- Chart on Japan - Market size and forecast (2023-2028) ($ billion)
- Data Table on Japan - Market size and forecast (2023-2028) ($ billion)
- Chart on Japan - Year-over-year growth (2023-2028) (%)
- Data Table on Japan - Year-over-year growth (2023-2028) (%)
- 10.17 Brazil - Market size and forecast (2023-2028)
- Chart on Brazil - Market size and forecast (2023-2028) ($ billion)
- Data Table on Brazil - Market size and forecast (2023-2028) ($ billion)
- Chart on Brazil - Year-over-year growth (2023-2028) (%)
- Data Table on Brazil - Year-over-year growth (2023-2028) (%)
- 10.18 Egypt - Market size and forecast (2023-2028)
- Chart on Egypt - Market size and forecast (2023-2028) ($ billion)
- Data Table on Egypt - Market size and forecast (2023-2028) ($ billion)
- Chart on Egypt - Year-over-year growth (2023-2028) (%)
- Data Table on Egypt - Year-over-year growth (2023-2028) (%)
- 10.19 UAE - Market size and forecast (2023-2028)
- Chart on UAE - Market size and forecast (2023-2028) ($ billion)
- Data Table on UAE - Market size and forecast (2023-2028) ($ billion)
- Chart on UAE - Year-over-year growth (2023-2028) (%)
- Data Table on UAE - Year-over-year growth (2023-2028) (%)
- 10.20 Oman - Market size and forecast (2023-2028)
- Chart on Oman - Market size and forecast (2023-2028) ($ billion)
- Data Table on Oman - Market size and forecast (2023-2028) ($ billion)
- Chart on Oman - Year-over-year growth (2023-2028) (%)
- Data Table on Oman - Year-over-year growth (2023-2028) (%)
- 10.21 Argentina - Market size and forecast (2023-2028)
- Chart on Argentina - Market size and forecast (2023-2028) ($ billion)
- Data Table on Argentina - Market size and forecast (2023-2028) ($ billion)
- Chart on Argentina - Year-over-year growth (2023-2028) (%)
- Data Table on Argentina - Year-over-year growth (2023-2028) (%)
- 10.22 KSA - Market size and forecast (2023-2028)
- Chart on KSA - Market size and forecast (2023-2028) ($ billion)
- Data Table on KSA - Market size and forecast (2023-2028) ($ billion)
- Chart on KSA - Year-over-year growth (2023-2028) (%)
- Data Table on KSA - Year-over-year growth (2023-2028) (%)
11 Drivers, Challenges, and Opportunity/Restraints
- 11.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2023 and 2028
- 11.4 Market opportunities/restraints
12 Competitive Landscape
- 12.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
- 12.3 Landscape disruption
- Overview on factors of disruption
- 12.4 Industry risks
- Impact of key risks on business
13 Competitive Analysis
- 13.2 Market positioning of companies
- Matrix on companies position and classification
- 13.3 Acclarent, Inc. (Johnson & Johnson)
- Acclarent, Inc. (Johnson & Johnson) - Overview
- Acclarent, Inc. (Johnson & Johnson) - Product / Service
- Acclarent, Inc. (Johnson & Johnson) - Key offerings
- 13.4 Amplifon S.p.A.
- Amplifon S.p.A. - Overview
- Amplifon S.p.A. - Product / Service
- Amplifon S.p.A. - Key offerings
- 13.5 Cochlear Limited
- Cochlear Limited - Overview
- Cochlear Limited - Product / Service
- Cochlear Limited - Key offerings
- 13.6 Demant A/S
- Demant A/S - Overview
- Demant A/S - Product / Service
- Demant A/S - Key offerings
- 13.7 GN Store Nord A/S
- GN Store Nord A/S - Overview
- GN Store Nord A/S - Product / Service
- GN Store Nord A/S - Key offerings
- 13.8 Karl Storz SE & Co. KG
- Karl Storz SE & Co. KG - Overview
- Karl Storz SE & Co. KG - Product / Service
- Karl Storz SE & Co. KG - Key offerings
- 13.9 Medtronic plc
- Medtronic plc - Overview
- Medtronic plc - Product / Service
- Medtronic plc - Key offerings
- 13.10 Olympus Corporation
- Olympus Corporation - Overview
- Olympus Corporation - Product / Service
- Olympus Corporation - Key offerings
- 13.11 Pentax Medical (HOYA Corporation)
- Pentax Medical (HOYA Corporation) - Overview
- Pentax Medical (HOYA Corporation) - Product / Service
- Pentax Medical (HOYA Corporation) - Key offerings
- 13.12 Richard Wolf GmbH
- Richard Wolf GmbH - Overview
- Richard Wolf GmbH - Product / Service
- Richard Wolf GmbH - Key offerings
- 13.13 Sonova Holding AG
- Sonova Holding AG - Overview
- Sonova Holding AG - Product / Service
- Sonova Holding AG - Key offerings
- 13.14 Stryker Corporation
- Stryker Corporation - Overview
- Stryker Corporation - Product / Service
- Stryker Corporation - Key offerings
- 13.15 Widex A/S (WS Audiology A/S)
- Widex A/S (WS Audiology A/S) - Overview
- Widex A/S (WS Audiology A/S) - Product / Service
- Widex A/S (WS Audiology A/S) - Key offerings
- 13.16 Wright Medical Group N.V. (Stryker Corporation)
- Wright Medical Group N.V. (Stryker Corporation) - Overview
- Wright Medical Group N.V. (Stryker Corporation) - Product / Service
- Wright Medical Group N.V. (Stryker Corporation) - Key offerings
- 13.17 Zimmer Biomet Holdings, Inc.
- Zimmer Biomet Holdings, Inc. - Overview
- Zimmer Biomet Holdings, Inc. - Product / Service
- Zimmer Biomet Holdings, Inc. - Key offerings
- 13.18 Merz Pharma GmbH & Co. KGaA
- Merz Pharma GmbH & Co. KGaA - Overview
- Merz Pharma GmbH & Co. KGaA - Product / Service
- Merz Pharma GmbH & Co. KGaA - Key offerings
- 13.19 Heraeus Holding GmbH
- Heraeus Holding GmbH - Overview
- Heraeus Holding GmbH - Product / Service
- Heraeus Holding GmbH - Key offerings
- 13.20 Integra LifeSciences Corporation
- Integra LifeSciences Corporation - Overview
- Integra LifeSciences Corporation - Product / Service
- Integra LifeSciences Corporation - Key offerings
- 13.21 Smith & Nephew plc
- Smith & Nephew plc - Overview
- Smith & Nephew plc - Product / Service
- Smith & Nephew plc - Key offerings
- 13.22 Stryker Corporation
- Stryker Corporation - Overview
- Stryker Corporation - Product / Service
- Stryker Corporation - Key offerings
- 13.23 Avante Health Solutions
- Avante Health Solutions - Overview
- Avante Health Solutions - Product / Service
- Avante Health Solutions - Key offerings
- 13.24 Baxter International Inc.
- Baxter International Inc. - Overview
- Baxter International Inc. - Product / Service
- Baxter International Inc. - Key offerings
- 13.25 Cochlear Ltd.
- Cochlear Ltd. - Overview
- Cochlear Ltd. - Product / Service
- Cochlear Ltd. - Key offerings
- 13.26 Coloplast AS
- Coloplast AS - Overview
- Coloplast AS - Product / Service
- Coloplast AS - Key offerings
- 13.27 Demant AS
- Demant AS - Overview
- Demant AS - Product / Service
- Demant AS - Key offerings
- 13.28 HOYA Corp.
- HOYA Corp. - Overview
- HOYA Corp. - Product / Service
- HOYA Corp. - Key offerings
- 13.29 Intermedica Group
- Intermedica Group - Overview
- Intermedica Group - Product / Service
- Intermedica Group - Key offerings
- 13.30 Johnson and Johnson Services Inc.
- Johnson and Johnson Services Inc. - Overview
- Johnson and Johnson Services Inc. - Product / Service
- Johnson and Johnson Services Inc. - Key offerings
- 13.31 KARL STORZ SE and Co. KG
- KARL STORZ SE and Co. KG - Overview
- KARL STORZ SE and Co. KG - Product / Service
- KARL STORZ SE and Co. KG - Key offerings
- 13.32 Lateral Medical
- Lateral Medical - Overview
- Lateral Medical - Product / Service
- Lateral Medical - Key offerings
- 13.33 MED EL Medical Electronics.
- MED EL Medical Electronics. - Overview
- MED EL Medical Electronics. - Product / Service
- MED EL Medical Electronics. - Key offerings
- 13.34 Medtronic Plc
- Medtronic Plc - Overview
- Medtronic Plc - Product / Service
- Medtronic Plc - Key offerings
- 13.35 Olympus Corp.
- Olympus Corp. - Overview
- Olympus Corp. - Product / Service
- Olympus Corp. - Key offerings
- 13.36 Richard Wolf GmbH
- Richard Wolf GmbH - Overview
- Richard Wolf GmbH - Product / Service
- Richard Wolf GmbH - Key offerings
- 13.37 Siemens Healthineers AG
- Siemens Healthineers AG - Overview
- Siemens Healthineers AG - Product / Service
- Siemens Healthineers AG - Key offerings
- 13.38 Smith and Nephew plc
- Smith and Nephew plc - Overview
- Smith and Nephew plc - Product / Service
- Smith and Nephew plc - Key offerings
- 13.39 Sonova AG
- Sonova AG - Overview
- Sonova AG - Product / Service
- Sonova AG - Key offerings
- 13.40 Starkey Laboratories Inc.
- Starkey Laboratories Inc. - Overview
- Starkey Laboratories Inc. - Product / Service
- Starkey Laboratories Inc. - Key offerings
- 13.41 Stryker Corp.
- Stryker Corp. - Overview
- Stryker Corp. - Product / Service
- Stryker Corp. - Key offerings
- 13.42 Widex AS
- Widex AS - Overview
- Widex AS - Product / Service
- Widex AS - Key offerings
14 Appendix
- 14.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
- 14.3 Currency conversion rates for US$
- Currency conversion rates for US$
- 14.4 Research methodology
- 14.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
- 14.9 360 degree market analysis
- 360 degree market analysis
- 14.10 List of abbreviations
INFORMATION SOURCES
DATA ANALYSIS
REPORT WRITING
Get the report (PDF) sent to your email within minutes.
Complimentary full Excel data with your report purchase.
